Table 1 Summary of the most relevant clinical data and FRAX scores of the patients

Mean^a/Median^b

SD^a/Min-Max^b

Mean^a/Median^b

SD^a/Min-Max^b

Age (years)^a

57.46

11.168

58.58

10.486

0.618 (−5.6–3.3)

Men (N)

Women (N)

9 (17.3%)

43 (82.7%)

2 (4.7%)

41 (95.3%)

0.104

Menopause at examination (N)

33/43 (76.67%)

35/41% (85.3%)

0.314

Weight (kg)^a

70.88

14.38

73.74

13.77

0.328 (−2.9–2.9)

Height (cm) ^a

164.12

7.56

163.7

7.1

0.308

(0.4–1.5)

BMI (kg/m²) ^a

26.39

5.58

27.5

4.6

0.318

(−1.1–1.1)

Vitamin D and calcium supplement (N)

34 (65.4%)

29 (67.4%)

0,833

25 OH Vitamin D3 level (nmol/L) ^b

59.5

15.2–125.2

62.5

27.5–129.2

0.196

BMD L1–4 (g/cm²)^a

1.04

0,238

1.07

0.159

0.557 (−0.08–0.07)

BMD femur (g/cm²) ^a

0.83

0,108

0.85

0.125

0.294 (−0.09–0.01)

Normal (N)

14 (27%)

23 (53.5%)

0.045

Osteopenia (N)

31 (60%)

17 (39.5%)

Osteoporosis (N)

7 (13.5%)

3 (7%)

Without DEXA^1a

9.68%

7.42

15.58%

10.91

0.008

 With DEXA^2a

9.44%

6.723

13.25%

9.43

0.053

 Steroid dose adjusted with DEXA^3a

9.54%

7.475

9.96%

7.968

0.884

Without DEXA^1a

3.06%

3.97

6.23%

7.20

0.022

 With DEXA^2a

2.77%

3.01

3.57%

5.08

0.811

 Steroid dose adjusted with DEXA^3a

2.87%

3.393

2.46%

3.382

0.128